Tag Archives: Pfizer

Novartis takes total control of Alcon

In a $28Bn USD operation, the Swiss Pharmaceutical buys the 52% of Alcon’s remanent stock from Nestlé. Novartis would own an approximate 77 percent interest in Alcon. The operation goes at least one and a half year earlier than estimated in … Continue reading

Posted in Alta Dirección, Mercadotecnia, Salud | Tagged , , , , , , , , , , , , , , | Leave a comment

Abbott buys Solvay Pharma Division on $7Bn USD

According to information published today at the Wall Street Journal, Abbott will buy Solvay’s Pharmaceutical Division in a $7Bn USD deal. The official communication could be published by both companies as early as monday morning. With this deal Abbott is … Continue reading

Posted in Alta Dirección, Mercadotecnia, Ventas | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Los últimos movimientos de GSK

Miguel A. Tovar, analista Español de la industria farmacéutica, nos comenta en su interesante blog Blogaceutics, sobre la compra de Stiefel por GlaxoSmithKline. Un buen análisis donde comenta la decisión de GSK por diversificar su futuro y sus adquisiciones en … Continue reading

Posted in Blogs, Mercadotecnia, Salud, Ventas | Tagged , , , , , | Leave a comment

GSK compra Stiefel por $3,600 millones de UDS / GSK buys Stiefel in $3.6Bn

English below  Hace apenas unas horas, The Wall Street Journal y The Financial Times daban a conocer la noticia sobre tratos a punto de cerrarse entre GlaxoSmithKlein (GSK) y Stiefel; donde el primero compraría al segundo. La noticia ha sido … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Pharma: Trust Deficit or the Biggest Image Problem ever faced?

  It was  Saturday afternoon; April 4th, to be precise. 7-time Tour de France winner and full-time cancer fighter: Lance Armstrong was in his born-state Texas, riding to give a speech in the PhRMA meeting in San Antonio. From his … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments